Allarity Therapeutics, Inc. Form 8-K Filing

Allarity Therapeutics, Inc. announced the additional closing of a private placement on December 23, 2025. The company agreed to issue and sell 255,103 shares of its common stock at $0.98 per share, for gross proceeds of approximately $250,000. These shares were not registered under the Securities Act of 1933, with the company relying on an exemption under Section 4(a)(2). The proceeds will be used for general corporate purposes and working capital. This transaction is a follow-on to a previous private placement on September 22, 2025, which resulted in gross proceeds of approximately $2.5 million. The company also noted that the securities issued will have restrictive legends affixed.